BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 31173518)

  • 1. Protein and Peptide Biomaterials for Engineered Subunit Vaccines and Immunotherapeutic Applications.
    Tsoras AN; Champion JA
    Annu Rev Chem Biomol Eng; 2019 Jun; 10():337-359. PubMed ID: 31173518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rational Design of Antigen Incorporation Into Subunit Vaccine Biomaterials Can Enhance Antigen-Specific Immune Responses.
    Tsoras AN; Wong KM; Paravastu AK; Champion JA
    Front Immunol; 2020; 11():1547. PubMed ID: 32849524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Getting peptide vaccines to work: just a matter of quality control?
    Celis E
    J Clin Invest; 2002 Dec; 110(12):1765-8. PubMed ID: 12488425
    [No Abstract]   [Full Text] [Related]  

  • 4. Improving Vaccine and Immunotherapy Design Using Biomaterials.
    Bookstaver ML; Tsai SJ; Bromberg JS; Jewell CM
    Trends Immunol; 2018 Feb; 39(2):135-150. PubMed ID: 29249461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Self-Assembly as a Molecular Strategy to Improve Immunotherapy.
    Froimchuk E; Carey ST; Edwards C; Jewell CM
    Acc Chem Res; 2020 Nov; 53(11):2534-2545. PubMed ID: 33074649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide-Based Treatment: A Promising Cancer Therapy.
    Xiao YF; Jie MM; Li BS; Hu CJ; Xie R; Tang B; Yang SM
    J Immunol Res; 2015; 2015():761820. PubMed ID: 26568964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Composite peptide-based vaccines for cancer immunotherapy (Review).
    Yang J; Zhang Q; Li K; Yin H; Zheng JN
    Int J Mol Med; 2015 Jan; 35(1):17-23. PubMed ID: 25395173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity.
    Silva AL; Soema PC; Slütter B; Ossendorp F; Jiskoot W
    Hum Vaccin Immunother; 2016 Apr; 12(4):1056-69. PubMed ID: 26752261
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in immunotherapy delivery from implantable and injectable biomaterials.
    Leach DG; Young S; Hartgerink JD
    Acta Biomater; 2019 Apr; 88():15-31. PubMed ID: 30771535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The central role played by peptides in the immune response and the design of peptide-based vaccines against infectious diseases and cancer.
    Jackson DC; Purcell AW; Fitzmaurice CJ; Zeng W; Hart DN
    Curr Drug Targets; 2002 Apr; 3(2):175-96. PubMed ID: 11958299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-Linked Peptide Nanoclusters for Delivery of Oncofetal Antigen as a Cancer Vaccine.
    Tsoras AN; Champion JA
    Bioconjug Chem; 2018 Mar; 29(3):776-785. PubMed ID: 29436221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptides for Vaccine Development.
    Hamley IW
    ACS Appl Bio Mater; 2022 Mar; 5(3):905-944. PubMed ID: 35195008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing the layer-by-layer assembly technique to design biomaterials vaccines for immune modulation in translational applications.
    Tang T; Weng T; Jia H; Luo S; Xu Y; Li L; Zhang P
    Biomater Sci; 2019 Feb; 7(3):715-732. PubMed ID: 30762040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carrier molecules for use in veterinary vaccines.
    Gerdts V; Mutwiri G; Richards J; van Drunen Littel-van den Hurk S; Potter AA
    Vaccine; 2013 Jan; 31(4):596-602. PubMed ID: 23219438
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Designing B-Cell Epitopes for Immunotherapy and Subunit Vaccines.
    Singh H; Gupta S; Gautam A; Raghava GP
    Methods Mol Biol; 2015; 1348():327-40. PubMed ID: 26424284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intracellular delivery of tumor antigenic peptides in biodegradable-polymer adjuvant for enhancing cancer immunotherapy.
    Li H; Ma W
    Curr Med Chem; 2014; 21(21):2357-66. PubMed ID: 25030301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Versatile Manipulations of Self-Assembled Proteins in Vaccine Design.
    Nguyen QD; Kikuchi K; Maity B; Ueno T
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathogen-like particles: biomimetic vaccine carriers engineered at the nanoscale.
    Rosenthal JA; Chen L; Baker JL; Putnam D; DeLisa MP
    Curr Opin Biotechnol; 2014 Aug; 28():51-8. PubMed ID: 24832075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Engineering DNA vaccines against infectious diseases.
    Lee J; Arun Kumar S; Jhan YY; Bishop CJ
    Acta Biomater; 2018 Oct; 80():31-47. PubMed ID: 30172933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Subunit vaccines--antigens, carriers, conjugation methods and the role of adjuvants].
    Jarząb A; Skowicki M; Witkowska D
    Postepy Hig Med Dosw (Online); 2013 Nov; 67():1128-43. PubMed ID: 24379254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.